Melatonin suppresses proinflammatory mediators in lipopolysaccharide‐stimulated CRL1999 cells via targeting MAPK, NF‐κB, c/EBPβ, and p300 signaling
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Melatonin is an indoleamine secreted by the pineal gland as well as a plant‐derived product that exerts potential anti‐inflammatory properties, but the mechanisms of action remain unclear. Here, we investigated the roles of melatonin in regulation of proinflammatory mediators and identified the underlying mechanisms in human vascular smooth muscle (VSM) cell line CRL1999 stimulated by lipopolysaccharide (LPS). We found that treatment with melatonin significantly inhibited the production and expression of TNF‐α and interleukin (IL)‐1β, cyclooxygenase‐2 (COX‐2), inducible nitric oxide synthase, prostaglandin E(2) (PGE2), and nitric oxide (NO) in a dose‐dependent manner. Moreover, we also found that the suppression of proinflammatory mediators by melatonin was mediated through inhibition of MAPK, NF‐κB, c/EBPβ, and p300 signaling in LPS‐stimulated CRL1999 cells. Treatment with melatonin markedly inhibited phosphorylation of ERK1/2, JNK, p38 MAPK, IκB‐α, and c/EBPβ, blocked binding of NF‐κB and c/EBPβ to promoters, and suppressed p300 histone acetyltransferase (HAT) activity and p300 HAT‐mediated NF‐κB acetylation. Transfection with an ERK‐, IκB‐, or c/EBPβ‐specific siRNA or pretreatment with an ERK‐, p38 MAPK‐, or p300‐selective inhibitor considerably abrogated the melatonin‐mediated inhibition of proinflammatory mediators. Conversely, exogenous overexpression of a constitutively active p300, but not its HAT mutant, effectively reversed the melatonin‐mediated inhibitions. Collectively, these results indicate that melatonin suppresses proinflammatory mediators by simultaneously targeting the multiple signaling such as ERK/p38 MAPK, c/EBPβ, NF‐κB, and p300, in LPS‐stimulated VSM cell line CRL1999, and suggest that melatonin is a potential candidate compound for the treatment of proinflammatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melatonin: Action as antioxidant and potential applications in human disease and aging
Bonnefont-Rousselot, D., & Collin, F. (2010) · Toxicology · doi:10.1016/j.tox.2010.04.008 · Cited by 320
Escames, G., Acuña-Castroviejo, D., López, L. C., Tan, D.-X., Maldonado, M. D., Sánchez-Hidalgo, M., León, J., & Reiter, R. J. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.9.0001 · Cited by 118 · cited 1×
“A number of studies have shown the ability of melatonin to reduce the inflammatory response to lipopolysaccharide (LPS) [24].”
Background
Cited by
Mauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J., & González‐Gallego, J. (2013) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01014.x · Cited by 626
Melatonin and inflammation-Story of a double-edged blade
Hardeland, R. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12525 · Cited by 455
Aging, melatonin, and the pro- and anti-inflammatory networks
Hardeland, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051223 · Cited by 337
Vriend, J., & Reiter, R. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.013 · Cited by 246
“…102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 Jun et al., 2013; Jung et al., 2009; Li et al., 2005; Min et al., 2012; Natarajan et al., 1995; Qin et al., 2012; Sayyed et al., 2013; Shi et al., 2012; Zhou et al., 2014).”
Tocharus, C., Puriboriboon, Y., Junmanee, T., Tocharus, J., Ekthuwapranee, K., & Govitrapong, P. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.026 · Cited by 96
Metadata
- Authors
- Shi, D., Xiao, X., Wang, J., Liu, L., Chen, W., Fu, L., Xie, F., Huang, W., & Deng, W.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2012-02-21
- Volume
- 53
- Issue
- 2
- Pages
- 154-165
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W1496541446
- Cited by
- 101
- References
- 2
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin suppresses proinflammatory mediators in lipopolysaccharide‐stimulated CRL1999 cells via targeting MAPK, NF‐κB, c/EBPβ, and p300 signaling. https://app.cochat.ai/papers/10.1111/j.1600-079x.2012.00982.x
- The paper
- Shi, D., Xiao, X., Wang, J., Liu, L., Chen, W., Fu, L., Xie, F., Huang, W., & Deng, W. (2012). Melatonin suppresses proinflammatory mediators in lipopolysaccharide‐stimulated CRL1999 cells via targeting MAPK, NF‐κB, c/EBPβ, and p300 signaling. Journal of Pineal Research. https://doi.org/10.1111/j.1600-079x.2012.00982.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.